highly significantP <0.0001
The prevalence of MetS was 35.73% with a highly significant female predominance (40.12% for women and 18.56% for men; P <0.0001).
The prevalence of MetS was 35.73% with a highly significant female predominance (40.12% for women and 18.56% for men; P <0.0001).